 |
 |
|
|
|
RESÚMENES ENERO 2010 |
Schizophrenia-Psychotic
Disorders & Antipsychotics
(Haga un click en la
información del journal
para acceder al resúmen)
5
– doble-ciego o
metanálisis; 4 – subanálisis o simple ciego; 3
– revisión, abierto, básico; 2 –
casos; 1 – opinión
GRATIS = Texto
gratuito en algunos países de la región iberoamericana
5 - High- v. low-dose quetiapine in
schizophrenia: meta-analysis
Nitesh Painuly
The Psychiatrist 2010 v. 34, p. 9-12.
GRATIS 3! - The cost of relapse and the predictors of
relapse in the treatment of schizophrenia
Haya
Ascher-Svanum, Baojin Zhu, Douglas E Faries, David Salkever, Eric P Slade, Xiaomei Peng and Robert R
Conley
3! - The role of histaminergic
H1 and H3 receptors in food intake: A mechanism for atypical
antipsychotic-induced weight gain?
Chao
Deng, Katrina Weston-Green and Xu-Feng Huang
3 - Serotonin transporter polymorphisms and early
response to antipsychotic treatment in first episode of psychosis
Javier
Vázquez-Bourgon, Maria Jesús Arranz, Ignacio Mata, José María Pelayo-Terán,
Rocío Pérez-Iglesias, Laura Medina-González, Eugenio Carrasco-Marín, José Luis
Vázquez-Barquero and Benedicto Crespo-Facorro
Psychiatry Research. Volume 175, Issue 3, 28
February 2010, Pages 189-194.
2 - Maintenance
electroconvulsive therapy: An alternative treatment for refractory
schizophrenia and schizoaffective disorders
Maryse Lévy-Rueff, Raphaël Gourevitch, Henri Lôo,
Jean-Pierre Olié and Isabelle Amado
Psychiatry Research. Volume
175, Issue 3, 28 February 2010, Pages 280-283.
3 - Polypharmacy and high-dose antipsychotic regimes in
the community
Tongeji E. Tungaraza, Seema Gupta, Jane
Jones, Rob Poole, Gary Slegg
The Psychiatrist (2010) 34: 44-46.
3 - Effects of atypical (risperidone) and typical
(haloperidol) antipsychotic agents on astroglial functions
André Quincozes-Santos,
Larissa Daniele Bobermin,
Rafaela Pestana Leques Tonial, Victorio Bambini-Junior,
Rudimar Riesgo and Carmem Gottfried
European Archives of
Psychiatry and Clinical Neuroscience. On
Line First, 2010.
3! -
Schizophrenia in the Offspring of Antenatally Depressed Mothers in the Northern
Finland 1966 Birth Cohort: Relationship to Family History of Psychosis
Pirjo
Mäki, Tiina Riekki, Jouko Miettunen, Matti Isohanni, Peter B. Jones, Graham K.
Murray, and Juha Veijola
Am J
Psychiatry 2010; 167:70-77.
3 - Antipsychotic Dose Equivalents and Dose-Years: A
Standardized Method for Comparing Exposure to Different Drugs
Nancy
C. Andreasen, Marcus Pressler, Peg Nopoulos, Del Miller and Beng-Choon Ho
Biological Psychiatry. Volume
67, Issue 3, 1 February 2010, Pages 255-262.
3! - Identification of Novel Candidate Genes for Treatment
Response to Risperidone and Susceptibility for Schizophrenia: Integrated
Analysis Among Pharmacogenomics, Mouse Expression, and Genetic Case-Control
Association Approaches
Masashi Ikeda, Yasuyuki Tomita,
Akihiro Mouri, Minori Koga, Tomo Okochi, Reiji Yoshimura, Yoshio Yamanouchi,
Yoko Kinoshita, Ryota Hashimoto, Hywel J. Williams, Masatoshi Takeda, Jun
Nakamura, Toshitaka Nabeshima, Michael J. Owen, Michael C. O'Donovan, Hiroyuki
Honda, Tadao Arinami, Norio Ozaki and Nakao Iwata
Biological Psychiatry. Volume
67, Issue 3, 1 February 2010, Pages 263-269.
3! - Cardiovascular Disease
Mortality in Patients With Chronic Schizophrenia Treated With Clozapine: A
Retrospective Cohort Study
Deanna L. Kelly, Robert P.
McMahon, Fang Liu, Raymond C. Love, Heidi J. Wehring, PharmD, Joo-Cheol Shim,
Kimberly R. Warren, and Robert R. Conley
J Clin Psychiatry. 2010 Jan 12. [Epub ahead
of print].
3 - Wellness-Activities to Prevent Metabolic Syndrome Among Patients with
Schizophrenia
Monika
Brönner, Christine Betz, Sarah Christ, Teresa Froböse,
Gabi Pitschel-Walz, Josef Bäuml
Psychiat
Prax 2010; 37(1): 7-19.
3! - Weight gain in
antipsychotic-naive patients: a review and meta-analysis
I. Tarricone, B. Ferrari Gozzi,
A. Serretti, D. Grieco and D. Berardi
Psychological Medicine
(2010), 40:187-200.
5 -
Modeling the Effectiveness of Paliperidone ER and Olanzapine in Schizophrenia:
Meta-Analysis of 3 Randomized, Controlled Clinical Trials
Ignacio Ortega, Juan
Jose Perez-Ruixo, Kim Stuyckens, Vladimir Piotrovsky, and An Vermeulen
The
Journal of Clinical Pharmacology First published on January 7, 2010.
3 -
Neuroleptic-Induced Catatonia: Clinical Presentation, Response to
Benzodiazepines, and Relationship to Neuroleptic Malignant Syndrome
Lee,
Joseph
Journal
of Clinical Psychopharmacology: February 2010 - Volume 30 - Issue 1 - pp 3-10.
3 - A
Comparison Study of Multiple Measures of Adherence to Antipsychotic Medication
in First-Episode Psychosis
Cassidy,
Clifford M; Rabinovitch, Mark; Schmitz, Norbert; Joober, Ridha; Malla, Ashok
Journal
of Clinical Psychopharmacology: February 2010 - Volume 30 - Issue 1 - pp 64-67.
3 -
Priapism Associated With Antipsychotics: Role of [alpha]1 Adrenoceptor Affinity
Andersohn,
Frank; Schmedt, Niklas; Weinmann, Stefan; Willich, Stefan N; Garbe, Edeltraut
Journal
of Clinical Psychopharmacology: February 2010 - Volume 30 - Issue 1 - pp 68-71.
5 - Metformin for weight reduction in non-diabetic
patients on antipsychotic drugs: a systematic review and meta-analysis
Linda Björkhem-Bergman, Annika B. Asplund, and Jonatan
D. Lindh
Journal of Psychopharmacology First published on
January 15, 2010.
3! - Lactational exposure to atypical antipsychotic drugs
disrupts the pituitary–testicular axis in mice neonates during post-natal development
Akash Chandra Mishra and Banalata Mohanty
Journal of Psychopharmacology First published on
January 15, 2010.
5 - Treatment of subsyndromal depressive symptoms in
middle-aged and older adults with schizophrenia: effect on functioning
John Kasckow, Nicole Lanouette, Thomas Patterson, Ian
Fellows, Shahrokh Golshan, Ellen Solorzano, Sidney Zisook
International Journal of Geriatric Psychiatry. Volume 25 Issue
2, Pages 183 - 190.
3 - Attenuation of
Phencyclidine-Induced Object Recognition Deficits by the Combination of
Atypical Antipsychotic Drugs and Pimavanserin (ACP 103), a 5-Hydroxytryptamine2A
Receptor Inverse Agonist
S.
Snigdha, M.
Horiguchi, M.
Huang, Z. Li, M.
Shahid, J. C.
Neill and H. Y.
Meltzer
JPET February 2010 vol. 332 no. 2 622-631.
3! -
Antipsychotic-Induced Hyponatraemia: A Systematic Review of the Published
Evidence
Meulendijks,
Didier; Mannesse, Cyndie K; Jansen, Paul A.F; van Marum, Rob J; Egberts, Toine
C.G
Drug
Safety: 1 February 2010 - Volume 33 - Issue 2 - pp 101-114.
3! - Sleep Disorders in Schizophrenia. Importance and Options for a Multi-Dimensional Support
J. Staedt,
M. Hauser, Y. Gudlowski, G. Stoppe
Fortschr
Neurol Psychiatr : Online First January 2010.
GRATIS 3 - Nonadherence to Medication Four Years After a First
Episode of Psychosis and Associated Risk Factors
Michele
Hill, Niall Crumlish, Petter Whitty, Mary Clarke, Stephen Browne, Moayyad
Kamali, Anthony Kinsella, John L. Waddington, Conall Larkin, and Eadbhard
O'Callaghan
Psychiatr
Serv 61:189-192, February 2010.
4 - Effect of bromocriptine on antipsychotic drug-induced
hyperprolactinemia: Eight-week randomized, single-blind, placebo-controlled,
multicenter study
Moon-Soo Lee, Hyun-Cheol Song, Hyonggin An, Jaewon Yang, Young-Hoon Ko, In-Kwa Jung, and Sook-Haeng Joe
Psychiatry and Clinical Neurosciences. Volume 64 Issue 1, Pages 19 - 27.
3< - Trial of aripiprazole in the treatment of
first-episode schizophrenia
Hwa-Young Lee, Byung-Joo Ham, Rhee-Hun Kang, Jong-Woo Paik, Sang-Woo Hahn, Moon-Soo Lee, and Min-Soo Lee
Psychiatry and Clinical Neurosciences. Volume 64 Issue 1, Pages 38 - 43.
3! - Clinical and pharmacologic risk factors for
neuroleptic malignant syndrome and their association with death
Ümit Tural, and Emin Önder
Psychiatry and Clinical Neurosciences. Volume 64 Issue 1, Pages 79 - 87.
3 -
Attempted suicide predicts suicide risk in schizophrenia spectrum psychosis
Andreas Carlborg, Jussi Jokinen, Anna-Lena Nordström, Erik G. Jönsson, Peter Nordström
Nordic Journal of
Psychiatry. February 2010, Vol. 64, No.
1, Pages 68-72.
5< - The effect of mirtazapine add on therapy to risperidone in the
treatment of schizophrenia: A double-blind randomized placebo-controlled trial
Seyed-Hesameddin
Abbasi, Haleh Behpournia, Aboulfazl Ghoreshi, Bahman Salehi, Maedeh Raznahan,
Shams-Ali Rezazadeh, Farzin Rezaei and Shahin Akhondzadeh
Schizophrenia Research. Volume 116, Issues 2-3,
February 2010, Pages 101-106.
5 -
Paliperidone palmitate maintenance treatment in delaying the time-to-relapse in
patients with schizophrenia: A randomized, double-blind, placebo-controlled
study
David
Hough, Srihari Gopal, Ujjwala Vijapurkar, Pilar Lim, Margarita Morozova and
Mariëlle Eerdekens
Schizophrenia Research. Volume 116, Issues 2-3,
February 2010, Pages 107-117.
3 -
High remission rates from an initial ultra-high risk state for psychosis
Andor E. Simon and Daniel
Umbricht
Schizophrenia
Research. Volume 116, Issues 2-3, February 2010, Pages 168-172.
3! - Later
paternal age and sex differences in schizophrenia symptoms
Paul J.
Rosenfield, Karine Kleinhaus, Mark Opler, Mary Perrin, Nicole Learned, Raymond
Goetz, Arielle Stanford, Julie Messinger, Jill Harkavy-Friedman and Dolores
Malaspina
Schizophrenia Research. Volume 116, Issues 2-3,
February 2010, Pages 191-195.
3! -
Differences in maternal and paternal age between Schizophrenia and other
psychiatric disorders
Jorge Lopez-Castroman, David
Delgado Gómez, Juan José Carballo Belloso, Pablo Fernandez-Navarro, M. Mercedes
Perez-Rodriguez, Ignacio Basurte Villamor, Francisco Ferre Navarrete, Consuelo
Morant Ginestar, Dianne Currier, Marta Reyes Torres, Mercedes Navio-Acosta,
Jerónimo Saiz-Ruiz, Miguel Angel Jimenez-Arriero and Enrique Baca-Garcia
Schizophrenia Research. Volume 116, Issues 2-3,
February 2010, Pages 184-190.
3! -
Abnormal cortisol levels during the day and cortisol awakening response in
first-episode psychosis: The role of stress and of antipsychotic treatment
Valeria
Mondelli, Paola Dazzan, Nilay Hepgul, Marta Di Forti, Monica Aas, Alessandro
D'Albenzio, Marco Di Nicola, Helen Fisher, Rowena Handley, Tiago Reis Marques,
Craig Morgan, Serena Navari, Heather Taylor, Andrew Papadopoulos, Katherine J.
Aitchison, Robin M. Murray and Carmine M. Pariante
Schizophrenia Research. Volume 116, Issues 2-3,
February 2010, Pages 234-242.
3< - Prospective, Open Study of Long-Acting Injected Risperidone versus Oral
Antipsychotics in 88 Chronically Psychotic Patients
P. Girardi,
G. Serafini, M. Pompili, M. Innamorati, R. Tatarelli, R.
J. Baldessarini
Pharmacopsychiatry
: Online First. January 2010.
3 - Generalizability of the
Results of Efficacy Trials in First-Episode Schizophrenia: Comparisons Between
Subgroups of Participants of the European First Episode Schizophrenia Trial
(EUFEST)
Han Boter, Eske M. Derks,
W. Wolfgang Fleischhacker, M. Davidson, and René S. Kahn, for the EUFEST Study
Group
J Clin Psychiatry
2010;71(1):58-65.
3 - The
Pharmacokinetics of Paliperidone Versus Risperidone
Jose de
Leon, Gary Wynn, and Neil B. Sandson
Psychosomatics
51:80-88, January-February 2010.
3 -
Risperidone Long-Acting Injection: Pharmacokinetics Following Administration in
Deltoid Versus Gluteal Muscle in Schizophrenic Patients
An
Thyssen, Sarah Rusch, Virginie Herben, Jorge Quiroz, and Erik Mannaert
The
Journal of Clinical Pharmacology, First published on January 23, 2010.
3 - Effects of Oral Ziprasidone
and Oral Haloperidol on QTc Interval in Patients with Schizophrenia or
Schizoaffective Disorder
Pharmacotherapy 2010; Volume: 30 | Issue: 2: 127-135.
GRATIS (previo
registro) 3 - Tratamiento
para la esquizofrenia. Revisión crítica sobre la farmacología y
mecanismos de acción de los antipsicóticos
K. Tajima, H. Fernández, J. J. López-Ibor, J. L. Carrasco y M. Díaz-Marsá
Actas Esp Psiquiatr
2009;37(6):330-342
3! - Mechanisms of Action of Antipsychotic Drugs of
Different Classes, Refractoriness to Therapeutic Effects of Classical
Neuroleptics, and Individual Variation in Sensitivity to their Actions: PART I
R. Miller
Current Neuropharmacology.
2010; Volume 7 Issue 4 : 302-314
GRATIS (previo registro) 3! - What to Make of CATIE: Are We Better Off With
Atypical Antipsychotics?
By Leslie Citrome
Psychiatric Times. Vol. 27 No. 2 January 8, 2010
| Regresar a RESÚMENES ENERO 2010 |
©
1999-2010 Jorge M Tamayo, MD, BMSS
Creada en Enero 1999
| Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA |